TABLE 2.
Reported induction of yoeB under various stress conditions
| Treatment | n-Fold changea (time [min]) | Reference |
|---|---|---|
| Cell wall biosynthesis | ||
| Vancomycin, 2 μg/ml | 19 (10) | 7 |
| Vancomycin, 0.5 μg/ml | 7.7 (40) | 16 |
| Cycloserine, 16 μg/ml | 15 (40) | 16 |
| Oxacillin, 0.25 μg/ml | 7 (40) | 16 |
| Ristocetin, 0.5 μg/ml | 7.8 (40) | 16 |
| Fosfomycin, 256 μg/ml | 10 (80) | 16 |
| Membrane-active compounds | ||
| Monensin, 0.125 μg/ml | 59 (40) | 16 |
| Polymyxin B, 64 μg/ml | 4.9 (40) | 16 |
| Nigericin, 0.008 μg/ml | 3.8 (40) | 16 |
| LL-37 | 9.1 (20) | 34 |
| Fatty acid biosynthesis | ||
| Triclosan, 1 μg/ml | 31 (10) | 16 |
| Cerulenin, 4 μg/ml | 8.6 (10) | 16 |
| Protein biosynthesis | ||
| Tetracycline, 0.5 μg/ml | 5.1 (40) | 16 |
| Oxidants | ||
| Diamide, 1 mM | 65 (50) | 22 |
| Paraquat, 100 μM | 13 (10) | 31 |
| Arsenate, 10 μM | ∼65 (3) | 29 |
a
In all cases, the n-fold change noted is the greatest for the conditions tested.